Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|August 22, 2017
Interleukin-10 Production by T and B Cells Is a Key Factor to Promote Systemic Salmonella enterica Serovar Typhimurium Infection in MiceGeraldyne A Salazar, Hernán F Peñaloza, Catalina Pardo-Roa, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium InfectionValentina P Sebastián, Daniela Moreno-Tapia, Felipe Melo-González, et al.
Frontiers in Immunology|May 17, 2021
Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae InfectionLiliana A González, Felipe Melo-González, Valentina P Sebastián, et al.
Frontiers in Immunology|October 18, 2021
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 VaccineLuisa F Duarte, Nicolás M S Gálvez, Carolina Iturriaga, et al.
Frontiers in Immunology|December 3, 2021
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineFelipe Melo-González, Jorge A Soto, Liliana A González, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Pageof 3